Outsourcing in Clinical Trials West Coast (OCT West)
Feb 11–12, 2025 Ended
Hyatt Regency San Francisco Airport · Burlingame, CA · In person
This conference will bring leading industry professionals together to share knowledge, with a focus on collaboration, advancing clinical development and concentrating on clinical operations, innovation, and technology.
- Venue
- Hyatt Regency San Francisco Airport
- Program
- 5 tracks · 72 sessions
- 70 speakers
- Organizer
- Arena International Events Group
Agenda
Show sessions in
Tue, Feb 11
-
7:30 AM
50 min
Break · Outsourcing & Clinical Operations
Registration & Refreshments
-
8:20 AM
10 min
-
8:30 AM
30 min
Keynote · Outsourcing & Clinical Operations
Keynote: How to optimize efficiencies at clinical trial sites when they’re underperforming
Leesa Gentry, RenovoRx
-
9:00 AM
30 min
Talk · Outsourcing & Clinical Operations
Why so slow? Insider insights from the clinic floor to speed up the conduct of proof-of-concept patient trials
Tatiana Eidus, ARENSIA Exploratory Medicine
-
9:30 AM
30 min
Talk · Outsourcing & Clinical Operations
Optimizing clinical trials: Sponsor/CRO cooperation; working together to enroll appropriate patients
Susan Edelstein, Ardelyx
-
10:00 AM
30 min
Talk · Outsourcing & Clinical Operations
Maximizing the consultative partnership between CRO and pharma/biotech partners
Marija Jovanovic, ICON
-
10:30 AM
30 min
Break · Outsourcing & Clinical Operations
Morning refreshments and networking break sponsored by Ergomed
-
11:00 AM
30 min
Talk · Patient Centricity and DEI
Ethical requirements and rights for patient disclosure and consent when implementing AI tools
-
11:00 AM
30 min
Talk · Clinical Technology & Innovation
How Machine Learning (ML) and human genetics are accelerating drug discovery: Foreseeing the impact on clinical trials
Matthew Albert, Octant Biosciences
-
11:00 AM
30 min
Talk · Outsourcing & Clinical Operations
Ensuring that vendor oversight is embedded from end-to-end
Laurin Vincent, Gilead
-
11:30 AM
30 min
Talk · Patient Centricity and DEI
From guidance to action: Diversity insights and industry trends
Stephanie Hitchcock, PCM Trials
-
11:30 AM
30 min
Talk · Clinical Technology & Innovation
End-to-End financial management: Challenges and opportunities
Zahiah Gueddar, IQVIA Technologies
-
11:30 AM
30 min
Talk · Outsourcing & Clinical Operations
The 2025 Biotech Landscape: Perspectives and Projections
Aditya Kotta, Novotech
-
12:00 PM
45 min
Panel · Patient Centricity and DEI
Panel discussion: Is clinical trial exclusion criteria too stringent?
Jad Adaimi, Ultragenyx Marla Williams, Exelixis Nisha Trivedi Meghan McKenzie, Genentech Cathy Scharf, Patient Advocates of the East Bay
-
12:00 PM
45 min
Panel · Clinical Technology & Innovation
Panel discussion: Translating technology into tangible outcomes and what are the latest ways in which it’s disrupting the clinical trial industry
Meir Pinco, BeiGene John Rootenberg, Genentech Joshua Cox, Eli Lilly and Company
-
12:00 PM
45 min
Panel · Outsourcing & Clinical Operations
Panel discussion: Battling insufficient resources to allow your trial to succeed in an increasingly competitive landscape
Sage Callaway, Ascendis Pharma Jenni Herber, Kamau Therapeutics Avnika Agarwal, ICON Susan Edelstein, Ardelyx Laura O’Donnell, GSK
-
12:45 PM
30 min
Talk · Patient Centricity and DEI
The benefits of building trials, focused on patients, delivered in their own community
Catherine Jervis, MRN
-
12:45 PM
30 min
Talk · Clinical Technology & Innovation
Unlocking trial success: How clinical adjudication drives sponsor and regulatory confidence in study results
Kathleen Dowell, Clario
-
12:45 PM
30 min
Talk · Outsourcing & Clinical Operations
Breaking through: Success in streamlining SAD/MAD and NDA-Enabling studies
Lona Sheeran, Worldwide Clinical Trials
-
1:15 PM
60 min
Break · Patient Centricity and DEI · Clinical Technology & Innovation · Outsourcing & Clinical Operations
Lunch and networking sponsored by Thermo Fisher Scientific
-
2:15 PM
30 min
Talk · Patient Centricity and DEI
Patient Engagement starts with the Informed Consent Form
Ros Cheetham, MacroGenics
-
2:15 PM
30 min
Talk · Clinical Technology & Innovation
Cross-functional team collaboration and alignment in meeting ‘on time’ clinical supply needs
Anthony L Colenburg Sr, Sutro Biopharma
-
2:15 PM
30 min
Talk · Outsourcing & Clinical Operations
Session reserved for Jenni Herber
Jenni Herber, Kamau Therapeutics
-
2:45 PM
30 min
Talk · Patient Centricity and DEI
Patient advocacy groups: Bridging clinical trials and patient communities for meaningful DEI impact
Sarah Cross, Premier Research
-
2:45 PM
30 min
Talk · Clinical Technology & Innovation
Maximizing asset valuation for biopharma
Kenneth Park, Fortrea
-
2:45 PM
30 min
Talk · Outsourcing & Clinical Operations
Driving success: Strategies for optimal site support
Eleanor Miller, PSI CRO
-
3:15 PM
30 min
-
3:15 PM
30 min
Talk · Clinical Technology & Innovation
Session reserved for Sharon Crugnale
Sharon Crugnale, Bitterroot Bio
-
3:15 PM
30 min
Fireside chat · Outsourcing & Clinical Operations
Fireside chat: Successful strategies on CRO FSP management, scaling teams, and bridging low-cost offshore footprint while maintaining quality and efficiency
Bao Dinh, Takeda David Larwood, Valley Fever Solutions
-
3:45 PM
30 min
Break · Patient Centricity and DEI · Clinical Technology & Innovation · Outsourcing & Clinical Operations
Afternoon refreshments and networking
-
4:15 PM
30 min
Talk · Patient Centricity and DEI
From endpoints to impact: Designing trials that resonate with patients
Andrew Feigin, Rho
-
4:15 PM
30 min
-
4:15 PM
30 min
Talk · Outsourcing & Clinical Operations
What do you mean you need equipment? Demystifying the complexities of the equipment supply chain
Jonathan Raven, Emsere Bryan Dunlap, Emsere
-
4:45 PM
Panel · Patient Centricity and DEI
Closing panel discussion: Innovative approaches to engage and retain patients in an era of recruitment struggles
Ros Cheetham, MacroGenics Bruce Morimoto, Alto Neuroscience Susan Edelstein, Ardelyx
-
4:45 PM
Panel · Clinical Technology & Innovation
Closing panel discussion: How sustainable drug development will empower and optimize the way clinical trials are planned to improve productivity and minimize costs
Joshua Cox, Eli Lilly and Company Yuyi Shen, Abcuro Sarah Hamirani, AbbVie Jasmina Jankicevic, RAPT Therapeutics Prasun Mishra, Precision BioPharma
-
4:45 PM
45 min
Panel · Outsourcing & Clinical Operations
Closing panel discussion: Macro perspective: Facilitating the harmonization and equivalence of working across regions
Leesa Gentry, RenovoRx Sandra Nino-Siddens, Ultragenyx Pharmaceutical Bogdan Sandica, ARENSIA Exploratory Medicine Revati Tatake, GlobalData Plc
-
5:30 PM
Other · Outsourcing & Clinical Operations
Chair’s closing remarks
Wed, Feb 12
-
8:30 AM
20 min
Break · Outsourcing & Clinical Operations
Registration and refreshments
-
8:50 AM
10 min
-
8:50 AM
10 min
-
8:50 AM
10 min
-
9:00 AM
30 min
-
9:00 AM
30 min
Keynote · Clinical Data Management
Keynote: Automating manual processes to improve decision-making and patient care
Meir Pinco, BeiGene
-
9:00 AM
30 min
Keynote · Outsourcing & Clinical Operations
Keynote: Designing trials to reduce patient and site burden
Shantheri Pai, Gilead
-
9:30 AM
30 min
Talk · Medical Devices
Building a robust medical device clinical development program: best practices and insights
Lian Cunningham, Endogenex
-
9:30 AM
30 min
Talk · Clinical Data Management
Integrating Risk-Based Quality Monitoring (RBQM) into each phase of the trial to ensure maximum efficiency and robust data validation processes
Thomas Tremblay, Trefoil Therapeutics
-
9:30 AM
30 min
Talk · Outsourcing & Clinical Operations
Beyond traditional labels: Customized outsourcing strategies for biotech and pharma
Neil Berger, Parexel
-
10:00 AM
30 min
Talk · Medical Devices
Remote study on a shoestring: lessons from an OTC clinical trial
Debbie Donovan, Materna Medical
-
10:00 AM
30 min
Panel · Clinical Data Management
Panel discussion: Choosing an outsourcing model: FSO vs FSP vs inhouse
Joshua Cox, Eli Lilly and Company Hayley Lane, Star Therapeutics Ros Cheetham, MacroGenics Thomas Tremblay, Trefoil Therapeutics Jenni Herber, Kamau Therapeutics
-
10:00 AM
30 min
Talk · Outsourcing & Clinical Operations
Winning the “Clinical Operations Super Bowl”: Regulatory inspections from a Clinical Operations perspective
Abby Kennedy, DermBiont Vineeta Gulati, CymaBay Therapeutics
-
10:30 AM
30 min
Talk · Medical Devices
Recent FDA guidance on clinical research topics and what it means to you
Katie Bessette, Abbott Laboratories
-
10:30 AM
30 min
-
10:30 AM
30 min
Talk · Outsourcing & Clinical Operations
Breaking Borders: Mastering the art of global business expansion to Japan
Katsura Kasahara, EPS Corporation
-
11:00 AM
45 min
Break · Outsourcing & Clinical Operations · Medical Devices · Clinical Data Management
Morning refreshments and networking
-
11:45 AM
30 min
Talk · Medical Devices
Global UDI Compliance: strategies for navigating unique device identification standards worldwide
Tania Pearson, Medtronic
-
11:45 AM
30 min
Talk · Clinical Data Management
Realizing the value of data sharing and outlining the supported initiatives to enhance data transparency
Bruce Morimoto, Alto Neuroscience
-
11:45 AM
30 min
Talk · Outsourcing & Clinical Operations
Examination of the World Health Organization’s (WHO) recently released guidance on best practices for clinical trials to enhance the efficiency and credibility of clinical research
Archana Sah, Society for Clinical Research Sites
-
12:15 PM
45 min
Panel · Medical Devices
Panel discussion: Key considerations for evaluating clinical vendors in effective study execution
Chitrang Dave, Avidity Biosciences Dorothy H. Kwok, Bodyport Rozanno Gonzales, Genentech
-
12:15 PM
45 min
Panel · Clinical Data Management
Panel discussion: Embracing innovative technologies in clinical data management: Opportunities and challenges
Joshua Cox, Eli Lilly and Company Janet Moga, Astellas Gene Therapies Prasun Mishra, Precision BioPharma Peter St. Wecker, UCB
-
12:15 PM
15 min
Talk · Outsourcing & Clinical Operations
Technology spotlight: Innovative Digital Opinion Leader Identification with Adnexi to Improve Trial Awareness
Sandra Shpilberg, Adnexi
-
12:30 PM
30 min
Talk · Outsourcing & Clinical Operations
Put on your “risk management goggles” when evaluating common areas of negotiations
Gina Morton, Calico and Genentech
-
1:00 PM
60 min
Break · Outsourcing & Clinical Operations · Medical Devices · Clinical Data Management
Lunch and networking
-
2:00 PM
30 min
Talk · Medical Devices
Strengthening partnerships and processes for clinical trial excellence in medical devices
Kathryn Wine, Novocuff
-
2:00 PM
30 min
Talk · Clinical Data Management
The 7 wondrous ways to immediately improve your R&D Financial Accruals process
Chris Chan, IGM Biosciences
-
2:00 PM
30 min
Talk · Outsourcing & Clinical Operations
Clinical trials in rare disease populations: challenges and opportunities, a case study
Jenelle Lin, Aditum Bio
-
2:30 PM
Other · Medical Devices
Chair’s closing remarks and close of stream
-
2:30 PM
Talk · Clinical Data Management
AI transforming healthcare and life sciences: From discovery to delivery
Prasun Mishra, Precision BioPharma
-
2:30 PM
30 min
Talk · Outsourcing & Clinical Operations
Closeout process of vendor strategy management beginning with a finish in mind
Amy Mou, Pfizer
-
3:00 PM
30 min
Break · Outsourcing & Clinical Operations
Afternoon refreshments, networking & prize draw in exhibition room
-
3:30 PM
60 min
Roundtable · Outsourcing & Clinical Operations
Speaker Hosted Round Tables
Bruce Morimoto, Alto Neuroscience Meghan McKenzie, Genentech Kade Shippy, Genentech Audrey Funwie, Genentech Gina Morton, Calico and Genentech
-
4:30 PM
Other · Outsourcing & Clinical Operations
Chair’s closing remarks and end of conference
Time to be announced
-
Networking · Patient Centricity and DEI · Clinical Technology & Innovation · Outsourcing & Clinical Operations
End of day 1 and networking drinks sponsored by Dr. Vince Clinical Research
Speakers
-
Ardelyx
-
RenovoRx
-
ARENSIA Exploratory Medicine
-
ICON
-
Octant Biosciences
-
Gilead
-
PCM Trials
-
IQVIA Technologies
-
Novotech
-
Ultragenyx
-
Exelixis
-
Genentech
-
Patient Advocates of the East Bay
-
BeiGene
-
Genentech
-
Eli Lilly and Company
-
Ascendis Pharma
-
Kamau Therapeutics
-
ICON
-
GSK
-
MRN
-
Clario
-
Worldwide Clinical Trials
-
MacroGenics
-
Sutro Biopharma
-
Premier Research
-
Fortrea
-
PSI CRO
-
Bitterroot Bio
-
Takeda
-
Valley Fever Solutions
-
Rho
-
uMotif
-
Emsere
-
Emsere
-
Alto Neuroscience
-
Abcuro
-
AbbVie
-
RAPT Therapeutics
-
Precision BioPharma
-
Ultragenyx Pharmaceutical
-
ARENSIA Exploratory Medicine
-
GlobalData Plc
-
Avidity Biosciences
-
Gilead
-
Endogenex
-
Trefoil Therapeutics
-
Parexel
-
Materna Medical
-
Star Therapeutics
-
DermBiont
-
CymaBay Therapeutics
-
Abbott Laboratories
-
EPS Corporation
-
Medtronic
-
Society for Clinical Research Sites
-
Bodyport
-
Genentech
-
Astellas Gene Therapies
-
UCB
-
Adnexi
-
Calico and Genentech
-
Novocuff
-
IGM Biosciences
-
Aditum Bio
-
Pfizer
-
Genentech
-
Genentech